Home › Ulcerative Colitis › Arkansas
Ulcerative Colitis clinical trials in Arkansas
4 studies for Ulcerative Colitis are looking for participants at sites in Arkansas.
Cities in Arkansas
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Preferred Research Partners - Site Number: 8400018, Little Rock
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Applied Research Center of Arkansas, Little Rock
- Preferred Research Partners, Little Rock
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT06598943A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Arkansas Children's (IP Address), Little Rock
- Arkansas Children's, Little Rock
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Jul 8, 2026 · NCT05287126A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Little Rock
- Mirador Therapeutics Selected Site, Little Rock
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.